Cloudflare to Speed Up Millions of Websites, Automatically and for Free
New technology can help browsers make the Internet 30% faster SAN FRANCISCO--(BUSINESS WIRE)--Cloudflare, Inc. (NYSE:…
5 years ago
MapleStory M Unveils New Dual Blade Class and Dual Blade Events in Latest Content Update
Update adds new area Victoria Road and Monster Park Events LOS ANGELES--(BUSINESS WIRE)--#DualBlade--Free-to-play mobile MMORPG…
5 years ago
CyberLink Releases 2021 Versions of its Award-Winning PowerDirector and other Multimedia Editing Software
The upgraded suite of software includes new smart AI tools, advanced precision controls and expands…
5 years ago
With Japan Embracing Diversity in the Wake of a Successful Paralympic Games, JNTO Introduces the Country’s “Accessible Tourism” Initiatives
TOKYO--(BUSINESS WIRE)--Japan National Tourism Organization (JNTO) is continuing to promote accessible tourism across Japan, aiming…
5 years ago
Seoul Biennale of Architecture and Urbanism 2021 Is Held on September 16
SEOUL, South Korea--(BUSINESS WIRE)--#CROSSROADS--The Seoul Biennale of Architecture & Urbanism 2021 is opened on September…
5 years ago
With Japan Embracing Diversity in the Wake of a Successful Paralympic Games, JNTO Introduces the Country’s “Accessible Tourism” Initiatives
TOKYO--(BUSINESS WIRE)--Japan National Tourism Organization (JNTO) is continuing to promote accessible tourism across Japan, aiming…
5 years ago
Seoul Biennale of Architecture and Urbanism 2021 Is Held on September 16
SEOUL, South Korea--(BUSINESS WIRE)--#CROSSROADS--The Seoul Biennale of Architecture & Urbanism 2021 is opened on September…
5 years ago
DESTINY-Gastric06 Phase 2 Trial of ENHERTU® Initiated in China in Patients with HER2 Positive Advanced Gastric Cancer
TOKYO & MUNICH & BASKING RIDGE, N.J.--(BUSINESS WIRE)--Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and…
5 years ago
IASO Biotherapeutics Secures $108 Million Series C Funding to Advance Global Development of Innovative Cell Therapies
PLEASANTON, Calif. & NANJING, China & SHANGHAI--(BUSINESS WIRE)--#BioPharmaceutical--IASO Biotherapeutics (IASO Bio), a clinical-stage biopharmaceutical company…
5 years ago
DESTINY-Gastric06 Phase 2 Trial of ENHERTU® Initiated in China in Patients with HER2 Positive Advanced Gastric Cancer
TOKYO & MUNICH & BASKING RIDGE, N.J.--(BUSINESS WIRE)--Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and…
5 years ago